Compare Heron Therapeutics Inc (HRTX) vs Marathon Digital Holdings Inc (MARA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Marathon Digital Holdings Inc — how do they compare? Heron Therapeutics Inc trades at $0.41 (market cap $68.01M), while Marathon Digital Holdings Inc trades at $9.65 (market cap $3.83B). The key difference: Marathon Digital Holdings Inc is far larger — about 56.3× Heron Therapeutics Inc's market cap, and Marathon Digital Holdings Inc is more actively traded (47,742,698 versus 1,891,941). Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Marathon Digital Holdings Inc for 22 Days on average.
| HRTX | MARA | |
|---|---|---|
Market Cap | $68.01M | $3.83B |
Volume | 1,891,941 | 47,742,698 |
Sector | Health | Financials |
52-Week High | $1.49 | $22.84 |
52-Week Low | $0.27 | $6.73 |
Typical Hold Time | 35 Days | 22 Days |
Enterprise Value | $174.75M | $5.87B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.3582, down 8.15% today, with a bullish technical signal from moving averages but mixed earnings. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates, continuing a trend of net losses. Analyst sentiment remains strongly positive with 89% buy ratings, though Zacks issued a Strong Sell rating in July 2026.
The outlook hinges on revenue stabilization and path to profitability. Investment opportunity lies in analyst optimism and product sales growth, but risks include persistent losses, high valuation multiples, and competitive pressures in the biotechnology sector.
MARA stock trades at $9.91, down 4.34% today, showing bearish technical momentum despite recent volatility. The company faces significant fundamental challenges with a net income margin of -429.71% and consecutive quarterly earnings misses. Analyst sentiment remains divided with equal buy/hold ratings, while recent news highlights the stock's sensitivity to broader market movements and Bitcoin-related sector trends.
The outlook remains challenging due to persistent losses and negative profitability metrics. While the consensus price target of $13.25 suggests potential upside, investors face substantial execution risks amid heavy cash burn and competitive pressures in the technology sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Marathon Digital Holdings Inc
Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.
Read more on MARA →
